ArticleJournal of experimental & clinical cancer research : CR2018

EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis.

Shaofei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.